Stoter G - Search Results

1

A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic solid tumours.

Verweij J, Planting A, van der Burg M, Stoter G. Verweij J, et al. Among authors: stoter g. J Cancer Res Clin Oncol. 1992;118(8):606-8. doi: 10.1007/BF01211805. J Cancer Res Clin Oncol. 1992. PMID: 1325463 Free article. Clinical Trial.

2

Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer.

Ten Tije AJ, Verweij J, Sparreboom A, Van Der Gaast A, Fowst C, Fiorentini F, Tursi J, Antonellini A, Mantel M, Hartman CM, Stoter G, Planting AS, De Jonge MJ. Ten Tije AJ, et al. Among authors: stoter g. Clin Cancer Res. 2003 Aug 1;9(8):2957-64. Clin Cancer Res. 2003. PMID: 12912942 Clinical Trial.

3

A phase II study of high dose ifosfamide in metastatic colorectal cancer.

Planting AS, van der Burg ME, Hoff AM, Verweij J, Stoter G. Planting AS, et al. Among authors: stoter g. Eur J Cancer Clin Oncol. 1989 Jan;25(1):139-40. doi: 10.1016/0277-5379(89)90062-x. Eur J Cancer Clin Oncol. 1989. PMID: 2920760 No abstract available.

4

Cyclophosphamide, hexamethylmelamine, adriamycin and cisplatin combination chemotherapy in mixed mesodermal sarcoma of the female genital tract.

Jansen RL, van der Burg ME, Verweij J, Stoter G. Jansen RL, et al. Among authors: stoter g. Eur J Cancer Clin Oncol. 1987 Aug;23(8):1131-3. doi: 10.1016/0277-5379(87)90145-3. Eur J Cancer Clin Oncol. 1987. PMID: 3115787

5

Mitomycin C is an inactive drug in the third-line treatment of hormone and chemotherapy refractory breast cancer.

Dees A, Verweij J, van Putten WL, Stoter G. Dees A, et al. Among authors: stoter g. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1343-7. doi: 10.1016/0277-5379(87)90118-0. Eur J Cancer Clin Oncol. 1987. PMID: 3119346

6

5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary.

van der Gaast A, Verweij J, Planting AS, Stoter G. van der Gaast A, et al. Among authors: stoter g. Eur J Cancer Clin Oncol. 1988 Apr;24(4):765-8. doi: 10.1016/0277-5379(88)90312-4. Eur J Cancer Clin Oncol. 1988. PMID: 3383976

7

Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam Cooperative Head and Neck Cancer Study Group.

Verweij J, Alexieva-Figusch J, de Boer MF, Reichgelt B, Stoter G. Verweij J, et al. Among authors: stoter g. Eur J Cancer Clin Oncol. 1988 Apr;24(4):795-6. doi: 10.1016/0277-5379(88)90318-5. Eur J Cancer Clin Oncol. 1988. PMID: 3383981 No abstract available.

8

Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancer.

Bontenbal M, Planting AS, Verweij J, de Wit R, Kruit WH, Stoter G, Klijn JG. Bontenbal M, et al. Among authors: stoter g. Breast Cancer Res Treat. 1995 May;34(2):185-9. doi: 10.1007/BF00665790. Breast Cancer Res Treat. 1995. PMID: 7647335 Free article. Clinical Trial.

9

Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumors.

Planting AS, van der Burg ME, de Boer-Dennert M, Stoter G, Verweij J. Planting AS, et al. Among authors: stoter g. Ann Oncol. 1995 Feb;6(2):190-2. doi: 10.1093/oxfordjournals.annonc.a059117. Ann Oncol. 1995. PMID: 7786826 Free article. Clinical Trial.

10

Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine.

Pronk LC, Planting AS, Oosterom R, Drogendijk TE, Stoter G, Verweij J. Pronk LC, et al. Among authors: stoter g. Eur J Cancer. 1994;30A(7):1019-22. doi: 10.1016/0959-8049(94)90135-x. Eur J Cancer. 1994. PMID: 7946566 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters